Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)

Historical Holders from Q4 2015 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
KURA on Nasdaq
Shares outstanding
87,001,862
Price per share
$10.39
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
83,953,188
Holdings value
$743,091,012
% of all portfolios
0%
Share change
+2,020,687
Value change
+$26,560,569
Average buys %
+0%
Average sells %
-0%
Number of holders
198
Price from insider filings
$9.78
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOTECHNOLOGY VALUE FUND L P 10% +31% $76,791,609 +$24,465,506 8,677,018 +47% BVF PARTNERS L P/IL 30 Sep 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 9.4% +39% $45,139,170 +$14,105,982 7,561,000 +45% SUVRETTA CAPITAL MANAGEMENT, LLC 31 Mar 2025
BlackRock, Inc. 7.8% -24% $37,784,428 -$9,582,172 6,329,050 -20% BlackRock, Inc. 31 Mar 2025
ARMISTICE CAPITAL, LLC 5.4% -28% $41,347,200 -$16,815,000 4,672,000 -29% Armistice Capital, LLC 30 Sep 2025
EcoR1 Capital, LLC 4.8% $25,284,000 4,200,000 EcoR1 Capital, LLC 30 Jun 2025
RA CAPITAL MANAGEMENT, L.P. 4.9% $23,907,522 4,004,610 RA Capital Management, L.P. 31 Mar 2025
As of 30 Sep 2025, Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 198 institutional shareholders filing 13F forms. They hold 83,953,188 shares of 87,001,862 outstanding shares (96%) .

Top 25 institutional shareholders own 78% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 11% 9,515,135 +0.47% 0% $84,208,945
BVF INC/IL 9.9% 8,617,162 +11% 3.1% $76,261,884
SUVRETTA CAPITAL MANAGEMENT, LLC 9.3% 8,116,000 0% 2.2% $71,826,600
VANGUARD GROUP INC 6.3% 5,468,522 +2.2% 0% $48,396,420
ARMISTICE CAPITAL, LLC 5.4% 4,672,000 -25% 1.3% $41,347,200
STATE STREET CORP 3.8% 3,343,131 +10% 0% $29,586,709
Prosight Management, LP 3.2% 2,758,516 -13% 5.9% $24,412,867
GOLDMAN SACHS GROUP INC 3% 2,614,726 +180% 0% $23,140,325
AQR CAPITAL MANAGEMENT LLC 2.6% 2,242,192 +138% 0.01% $19,843,399
JACOBS LEVY EQUITY MANAGEMENT, INC 2.6% 2,224,590 +102% 0.08% $19,687,622
MILLENNIUM MANAGEMENT LLC 2.4% 2,093,702 -20% 0.01% $18,529,263
GEODE CAPITAL MANAGEMENT, LLC 2.4% 2,047,926 +1.7% 0% $18,127,511
MORGAN STANLEY 2.1% 1,813,064 -8.6% 0% $16,045,621
Qube Research & Technologies Ltd 2% 1,712,716 -10% 0.02% $15,157,537
ALETHEA CAPITAL MANAGEMENT, LLC 1.6% 1,388,794 +46% 7.9% $12,290,827
Assenagon Asset Management S.A. 1.5% 1,265,030 +38% 0.02% $11,195,516
DIMENSIONAL FUND ADVISORS LP 1.3% 1,139,365 -8.3% 0% $10,083,861
ACADIAN ASSET MANAGEMENT LLC 1.2% 1,060,829 +22% 0.02% $9,387,000
ALGERT GLOBAL LLC 1.2% 1,011,945 -5.4% 0.15% $8,956,000
EcoR1 Capital, LLC 1% 872,500 -79% 0.37% $7,721,625
RENAISSANCE TECHNOLOGIES LLC 0.99% 865,310 -18% 0.01% $7,657,994
CITADEL ADVISORS LLC 0.93% 808,818 +122% 0.01% $7,158,040
NORTHERN TRUST CORP 0.87% 753,600 +8.6% 0% $6,669,361
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.82% 711,896 +1.8% 0% $6,300,280
AMERICAN CENTURY COMPANIES INC 0.77% 669,046 +187% 0% $5,921,057

Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 140,663 $1,344,895 +$141,976 $10.39 6
2025 Q3 83,953,188 $743,091,012 +$26,560,569 $8.85 198
2025 Q2 82,161,271 $474,076,451 +$3,886,066 $5.77 180
2025 Q1 80,481,583 $531,240,618 -$1,740,529 $6.60 183
2024 Q4 78,799,607 $686,298,457 -$217,678,180 $8.71 184
2024 Q3 82,360,607 $1,606,956,737 +$3,955,490 $19.54 178
2024 Q2 80,464,005 $1,656,732,694 -$4,363,479 $20.59 173
2024 Q1 80,692,487 $1,721,138,041 +$49,498,569 $21.33 163
2023 Q4 40,159 $576,716 -$446,397 $14.34 2
2023 Q3 75,153,989 $685,383,981 -$2,892,869 $9.12 129
2023 Q2 75,132,461 $794,961,873 +$20,118,037 $10.58 146
2023 Q1 72,441,228 $885,154,794 +$27,485,946 $12.23 139
2022 Q4 70,128,598 $870,155,639 -$24,769,337 $12.41 137
2022 Q3 71,548,279 $977,310,285 -$9,868,000 $13.66 139
2022 Q2 68,634,915 $1,258,068,611 +$54,229,438 $18.33 140
2022 Q1 64,650,945 $1,039,489,952 +$41,719,245 $16.08 137
2021 Q4 62,025,343 $868,581,054 -$106,142,238 $14.00 137
2021 Q3 65,734,221 $1,231,218,263 -$23,395,246 $18.73 147
2021 Q2 66,615,329 $1,388,931,935 -$37,869,506 $20.85 162
2021 Q1 68,451,675 $1,938,731,592 +$124,746,977 $28.27 160
2020 Q4 62,518,041 $2,042,133,962 +$338,978,921 $32.66 184
2020 Q3 53,148,772 $1,628,424,751 +$43,228,140 $30.64 157
2020 Q2 52,176,126 $851,151,913 +$209,126,635 $16.30 125
2020 Q1 39,615,341 $392,701,391 +$5,317,694 $9.95 111
2019 Q4 38,791,574 $533,386,217 -$12,767,491 $13.75 123
2019 Q3 39,227,572 $595,018,193 +$25,301,338 $15.17 111
2019 Q2 37,287,112 $734,201,288 +$137,666,395 $19.69 119
2019 Q1 30,403,832 $503,898,947 +$1,160,808 $16.59 96
2018 Q4 30,498,627 $427,879,020 -$2,835,798 $14.04 92
2018 Q3 30,139,808 $527,471,625 +$9,418,981 $17.50 109
2018 Q2 29,713,906 $537,504,780 +$109,387,451 $18.20 107
2018 Q1 23,486,848 $440,365,325 +$77,107,009 $18.75 96
2017 Q4 18,003,680 $275,443,651 -$7,194,972 $15.30 71
2017 Q3 19,217,641 $287,261,810 +$126,558,545 $14.95 63
2017 Q2 10,813,395 $100,551,904 +$4,770,964 $9.30 42
2017 Q1 10,310,503 $90,718,000 +$4,182,421 $8.80 34
2016 Q4 9,877,148 $58,241,000 +$735,497 $5.90 29
2016 Q3 9,749,053 $60,932,000 +$2,799,335 $6.25 26
2016 Q2 9,319,042 $25,248,000 -$2,970,812 $2.71 25
2016 Q1 10,225,108 $40,701,709 -$957,342 $4.05 19
2015 Q4 10,246,869 $86,073,000 +$80,323,987 $8.40 14